AllianceBernstein
FURX

AllianceBernstein’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

AllianceBernstein’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,900
Closed -$1.16M – 3534
2014
Q2 		$1.16M Buy
10,900
+1,040
+11% +$102K ﹤0.01% 2159
2014
Q1 		$858K Buy
9,860
+4,523
+85% +$349K ﹤0.01% 2237
2013
Q4 		$224K Sell
5,337
-100
-2% -$4.11K ﹤0.01% 2759
2013
Q3 		$239K Sell
5,437
-1,068
-16% -$44.2K ﹤0.01% 2801
2013
Q2 		$222K Buy
+6,505
New +$228K ﹤0.01% 2814

AllianceBernstein's FURX Position: Q3 2014 in Review

AllianceBernstein sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 10,900 shares — an estimated $1.16M sold.

AllianceBernstein first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $1.16M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • AllianceBernstein reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • AllianceBernstein sold 10,900 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $1.16M.
  • AllianceBernstein first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • AllianceBernstein's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.16M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on AllianceBernstein's 13F filing for Q3 2014, filed 13 Nov 2014.